Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort

Abstract Background Severe iodine insufficiency in pregnancy has significant consequences, but there is inadequate evidence to indicate what constitutes mild or moderate insufficiency, in terms of observed detrimental effects on pregnancy or birth outcomes. A limited number of studies have examined...

Full description

Bibliographic Details
Main Authors: Charles Jonathan Peter Snart, Diane Erin Threapleton, Claire Keeble, Elizabeth Taylor, Dagmar Waiblinger, Stephen Reid, Nisreen A. Alwan, Dan Mason, Rafaq Azad, Janet Elizabeth Cade, Nigel A. B. Simpson, Sarah Meadows, Amanda McKillion, Gillian Santorelli, Amanda H. Waterman, Michael Zimmermann, Paul M. Stewart, John Wright, Mark Mon-Williams, Darren Charles Greenwood, Laura J. Hardie
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Medicine
Subjects:
SGA
Online Access:http://link.springer.com/article/10.1186/s12916-020-01602-0
id doaj-0ebb4878455b4f7fa34843605f26436e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Charles Jonathan Peter Snart
Diane Erin Threapleton
Claire Keeble
Elizabeth Taylor
Dagmar Waiblinger
Stephen Reid
Nisreen A. Alwan
Dan Mason
Rafaq Azad
Janet Elizabeth Cade
Nigel A. B. Simpson
Sarah Meadows
Amanda McKillion
Gillian Santorelli
Amanda H. Waterman
Michael Zimmermann
Paul M. Stewart
John Wright
Mark Mon-Williams
Darren Charles Greenwood
Laura J. Hardie
spellingShingle Charles Jonathan Peter Snart
Diane Erin Threapleton
Claire Keeble
Elizabeth Taylor
Dagmar Waiblinger
Stephen Reid
Nisreen A. Alwan
Dan Mason
Rafaq Azad
Janet Elizabeth Cade
Nigel A. B. Simpson
Sarah Meadows
Amanda McKillion
Gillian Santorelli
Amanda H. Waterman
Michael Zimmermann
Paul M. Stewart
John Wright
Mark Mon-Williams
Darren Charles Greenwood
Laura J. Hardie
Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
BMC Medicine
Birthweight
Iodine
Pregnancy
Insufficiency
SGA
author_facet Charles Jonathan Peter Snart
Diane Erin Threapleton
Claire Keeble
Elizabeth Taylor
Dagmar Waiblinger
Stephen Reid
Nisreen A. Alwan
Dan Mason
Rafaq Azad
Janet Elizabeth Cade
Nigel A. B. Simpson
Sarah Meadows
Amanda McKillion
Gillian Santorelli
Amanda H. Waterman
Michael Zimmermann
Paul M. Stewart
John Wright
Mark Mon-Williams
Darren Charles Greenwood
Laura J. Hardie
author_sort Charles Jonathan Peter Snart
title Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
title_short Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
title_full Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
title_fullStr Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
title_full_unstemmed Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohort
title_sort maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a uk birth cohort
publisher BMC
series BMC Medicine
issn 1741-7015
publishDate 2020-06-01
description Abstract Background Severe iodine insufficiency in pregnancy has significant consequences, but there is inadequate evidence to indicate what constitutes mild or moderate insufficiency, in terms of observed detrimental effects on pregnancy or birth outcomes. A limited number of studies have examined iodine status and birth outcomes, finding inconsistent evidence for specific outcomes. Methods Maternal iodine status was estimated from spot urine samples collected at 26–28 weeks’ gestation from 6971 mothers in the Born in Bradford birth cohort. Associations with outcomes were examined for both urinary iodine concentration (UIC) and iodine-to-creatinine ratio (I:Cr). Outcomes assessed included customised birthweight (primary outcome), birthweight, small for gestational age (SGA), low birthweight, head circumference and APGAR score. Results There was a small positive association between I:Cr and birthweight in adjusted analyses. For a typical participant, the predicted birthweight centile at the 25th percentile of I:Cr (59 μg/g) was 2.7 percentage points lower than that at the 75th percentile of I:Cr (121 μg/g) (99% confidence interval (CI) 0.8 to 4.6), birthweight was predicted to be 41 g lower (99% CI 13 to 69) and the predicted probability of SGA was 1.9 percentage points higher (99% CI 0.0 to 3.7). There was no evidence of associations using UIC or other birth outcomes, including stillbirth, preterm birth, ultrasound growth measures or congenital anomalies. Conclusion Lower maternal iodine status was associated with lower birthweight and greater probability of SGA. Whilst small, the effect size for lower iodine on birthweight is comparable to environmental tobacco smoke exposure. Iodine insufficiency is avoidable, and strategies to avoid deficiency in women of reproductive age should be considered. Trial registration ClinicalTrials.gov NCT03552341 . Registered on June 11, 2018.
topic Birthweight
Iodine
Pregnancy
Insufficiency
SGA
url http://link.springer.com/article/10.1186/s12916-020-01602-0
work_keys_str_mv AT charlesjonathanpetersnart maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT dianeerinthreapleton maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT clairekeeble maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT elizabethtaylor maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT dagmarwaiblinger maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT stephenreid maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT nisreenaalwan maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT danmason maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT rafaqazad maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT janetelizabethcade maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT nigelabsimpson maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT sarahmeadows maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT amandamckillion maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT gilliansantorelli maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT amandahwaterman maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT michaelzimmermann maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT paulmstewart maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT johnwright maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT markmonwilliams maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT darrencharlesgreenwood maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
AT laurajhardie maternaliodinestatusintrauterinegrowthbirthoutcomesandcongenitalanomaliesinaukbirthcohort
_version_ 1724542249590587392
spelling doaj-0ebb4878455b4f7fa34843605f26436e2020-11-25T03:38:26ZengBMCBMC Medicine1741-70152020-06-0118111110.1186/s12916-020-01602-0Maternal iodine status, intrauterine growth, birth outcomes and congenital anomalies in a UK birth cohortCharles Jonathan Peter Snart0Diane Erin Threapleton1Claire Keeble2Elizabeth Taylor3Dagmar Waiblinger4Stephen Reid5Nisreen A. Alwan6Dan Mason7Rafaq Azad8Janet Elizabeth Cade9Nigel A. B. Simpson10Sarah Meadows11Amanda McKillion12Gillian Santorelli13Amanda H. Waterman14Michael Zimmermann15Paul M. Stewart16John Wright17Mark Mon-Williams18Darren Charles Greenwood19Laura J. Hardie20Leeds Institute of Cardiovascular & Metabolic Medicine, LIGHT Laboratories, School of Medicine, University of LeedsLeeds Institute of Cardiovascular & Metabolic Medicine, LIGHT Laboratories, School of Medicine, University of LeedsLeeds Institute for Data Analytics, University of LeedsLeeds Institute of Cardiovascular & Metabolic Medicine, LIGHT Laboratories, School of Medicine, University of LeedsBradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation TrustEarth Surface Science Institute, School of Earth and Environment, University of LeedsSchool of Primary Care and Population Sciences, Faculty of Medicine, Southampton General Hospital, University of SouthamptonBradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation TrustBradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation TrustNutritional Epidemiology Group, School of Food Science & Nutrition, University of LeedsDivision of Women’s and Children’s Health, School of Medicine, University of LeedsElsie Widdowson Laboratory, University of CambridgeElsie Widdowson Laboratory, University of CambridgeBradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation TrustSchool of Psychology, University of LeedsLaboratory for Human Nutrition, Institute of Food, Nutrition and Health, ETH ZurichFaculty of Medicine and Health, University of LeedsBradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation TrustSchool of Psychology, University of LeedsLeeds Institute of Cardiovascular & Metabolic Medicine, LIGHT Laboratories, School of Medicine, University of LeedsLeeds Institute of Cardiovascular & Metabolic Medicine, LIGHT Laboratories, School of Medicine, University of LeedsAbstract Background Severe iodine insufficiency in pregnancy has significant consequences, but there is inadequate evidence to indicate what constitutes mild or moderate insufficiency, in terms of observed detrimental effects on pregnancy or birth outcomes. A limited number of studies have examined iodine status and birth outcomes, finding inconsistent evidence for specific outcomes. Methods Maternal iodine status was estimated from spot urine samples collected at 26–28 weeks’ gestation from 6971 mothers in the Born in Bradford birth cohort. Associations with outcomes were examined for both urinary iodine concentration (UIC) and iodine-to-creatinine ratio (I:Cr). Outcomes assessed included customised birthweight (primary outcome), birthweight, small for gestational age (SGA), low birthweight, head circumference and APGAR score. Results There was a small positive association between I:Cr and birthweight in adjusted analyses. For a typical participant, the predicted birthweight centile at the 25th percentile of I:Cr (59 μg/g) was 2.7 percentage points lower than that at the 75th percentile of I:Cr (121 μg/g) (99% confidence interval (CI) 0.8 to 4.6), birthweight was predicted to be 41 g lower (99% CI 13 to 69) and the predicted probability of SGA was 1.9 percentage points higher (99% CI 0.0 to 3.7). There was no evidence of associations using UIC or other birth outcomes, including stillbirth, preterm birth, ultrasound growth measures or congenital anomalies. Conclusion Lower maternal iodine status was associated with lower birthweight and greater probability of SGA. Whilst small, the effect size for lower iodine on birthweight is comparable to environmental tobacco smoke exposure. Iodine insufficiency is avoidable, and strategies to avoid deficiency in women of reproductive age should be considered. Trial registration ClinicalTrials.gov NCT03552341 . Registered on June 11, 2018.http://link.springer.com/article/10.1186/s12916-020-01602-0BirthweightIodinePregnancyInsufficiencySGA